These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8454106)

  • 1. High risk of progression to NIDDM in South-African Indians with impaired glucose tolerance.
    Motala AA; Omar MA; Gouws E
    Diabetes; 1993 Apr; 42(4):556-63. PubMed ID: 8454106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transient impaired glucose tolerance in South African Indians does not carry a risk for progression to NIDDM.
    Motala AA; Omar MA; Gouws E
    Diabetes Care; 1997 Jul; 20(7):1101-7. PubMed ID: 9203444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progression to type 2 diabetes among high-risk groups in Kin-Chen, Kinmen. Exploring the natural history of type 2 diabetes.
    Chou P; Li CL; Wu GS; Tsai ST
    Diabetes Care; 1998 Jul; 21(7):1183-7. PubMed ID: 9653617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A two-step strategy for identification of high-risk subjects for a clinical trial of prevention of NIDDM.
    Narayan KM; Hanson RL; Pettitt DJ; Bennett PH; Knowler WC
    Diabetes Care; 1996 Sep; 19(9):972-8. PubMed ID: 8875091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypertriglyceridemia in different degrees of glucose intolerance in a Finnish population-based study.
    Salomaa VV; Tuomilehto J; Jauhiainen M; Korhonen HJ; Stengård J; Uusitupa M; Pitkanen M; Penttila I
    Diabetes Care; 1992 May; 15(5):657-65. PubMed ID: 1516486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasminogen activator inhibitor (PAI-1) activity is elevated in Asian and Caucasian subjects with non-insulin-dependent (type 2) diabetes but not in those with impaired glucose tolerance (IGT) or non-diabetic Asians.
    Nagi DK; Mohamed Ali V; Jain SK; Walji S; Yudkin JS
    Diabet Med; 1996 Jan; 13(1):59-64. PubMed ID: 8741814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for NIDDM in white population. Paris prospective study.
    Charles MA; Fontbonne A; Thibult N; Warnet JM; Rosselin GE; Eschwege E
    Diabetes; 1991 Jul; 40(7):796-9. PubMed ID: 2060716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of genetic prediabetic south Indian subjects. Importance of hyperinsulinemia and beta-cell dysfunction.
    Snehalatha C; Ramachandran A; Satyavani K; Latha E; Viswanathan V
    Diabetes Care; 1998 Jan; 21(1):76-9. PubMed ID: 9538973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proinsulin levels predict the development of non-insulin-dependent diabetes mellitus (NIDDM) in Japanese-American men.
    Kahn SE; Leonetti DL; Prigeon RL; Boyko EJ; Bergstom RW; Fujimoto WY
    Diabet Med; 1996 Sep; 13(9 Suppl 6):S63-6. PubMed ID: 8894485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of non-esterified fatty acids in the deterioration of glucose tolerance in Caucasian subjects: results of the Paris Prospective Study.
    Charles MA; Eschwège E; Thibult N; Claude JR; Warnet JM; Rosselin GE; Girard J; Balkau B
    Diabetologia; 1997 Sep; 40(9):1101-6. PubMed ID: 9300248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin and glucose levels and prevalence of glucose intolerance in pedigrees with multiple diabetic siblings.
    Elbein SC; Maxwell TM; Schumacher MC
    Diabetes; 1991 Aug; 40(8):1024-32. PubMed ID: 1860554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High prevalence of abnormal glucose tolerance and metabolic disturbances in first degree relatives of NIDDM patients. A study in Catalonia, a mediterranean community.
    Costa A; Rios M; Casamitjana R; Gomis R; Conget I
    Diabetes Res Clin Pract; 1998 Sep; 41(3):191-6. PubMed ID: 9829348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired glucose tolerance and NIDDM: does a lifestyle intervention program have an effect?
    Bourn DM; Mann JI; McSkimming BJ; Waldron MA; Wishart JD
    Diabetes Care; 1994 Nov; 17(11):1311-9. PubMed ID: 7821173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The natural history of progression from normal glucose tolerance to type 2 diabetes in the Baltimore Longitudinal Study of Aging.
    Meigs JB; Muller DC; Nathan DM; Blake DR; Andres R;
    Diabetes; 2003 Jun; 52(6):1475-84. PubMed ID: 12765960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of glucose intolerance in Asian Indians. Urban-rural difference and significance of upper body adiposity.
    Ramachandran A; Snehalatha C; Dharmaraj D; Viswanathan M
    Diabetes Care; 1992 Oct; 15(10):1348-55. PubMed ID: 1425100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma oxidizability in subjects with normal glucose tolerance, impaired glucose tolerance, and NIDDM.
    Haffner SM; Agil A; Mykkanen L; Stern MP; Jialal I
    Diabetes Care; 1995 May; 18(5):646-53. PubMed ID: 8586002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poor physical fitness, and impaired early insulin response but late hyperinsulinaemia, as predictors of NIDDM in middle-aged Swedish men.
    Eriksson KF; Lindgärde F
    Diabetologia; 1996 May; 39(5):573-9. PubMed ID: 8739917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for impaired pancreatic beta cell function in South African Indians with impaired glucose tolerance.
    Motala AA; Omar MA
    Diabet Med; 1994 Jun; 11(5):437-44. PubMed ID: 8088120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective study of health check examinees for the development of non-insulin-dependent diabetes mellitus: relationship of the incidence of diabetes with the initial insulinogenic index and degree of obesity.
    Kosaka K; Kuzuya T; Yoshinaga H; Hagura R
    Diabet Med; 1996 Sep; 13(9 Suppl 6):S120-6. PubMed ID: 8894495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive risk factors for deterioration from normoglycemic state to type 2 diabetes mellitus or impaired glucose tolerance in a Tunisian urban population.
    Chihaoui M; Kanoun F; Ben Rehaiem B; Ben Brahim S; Ftouhi B; Mekaouar A; Fekih M; Mbazâd A; Zouari B; Ben Khalifa F
    Diabetes Metab; 2001 Sep; 27(4 Pt 1):487-95. PubMed ID: 11547223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.